Feds relax enforcement policy in states with medical marijuana laws
On October 19, 2009, Attorney General Eric Holder announced formal guidelines for federal prosecutors in states that have enacted laws authorizing the use of marijuana for medical purposes. The guidelines are contained in a memo from Deputy Attorney General David W. Ogden, which was sent to the US Attorneys. Since these laws vary in their substantive provisions, and in the extent of state regulatory oversight from state to state, the memo provides uniform guidance to focus federal investigations and prosecutions in these states on core federal enforcement priorities.
The guidelines make clear that the focus of federal resources should not be on individuals whose actions are in compliance with existing state laws, while underscoring that the Department of Justice will continue to prosecute people whose claims of compliance with state and local law conceal operations inconsistent with the terms, conditions or purposes of those laws.
“It will not be a priority to use federal resources to prosecute patients with serious illnesses or their caregivers who are complying with state laws on medical marijuana, but we will not tolerate drug traffickers who hide behind claims of compliance with state law to mask activities that are clearly illegal,” Holder said. “This balanced policy formalizes a sensible approach that the Department has been following since January: effectively focus our resources on serious drug traffickers while taking into account state and local laws.”
The guidelines set forth examples of conduct that would show when individuals are not in clear and unambiguous compliance with applicable state law and may indicate illegal drug trafficking activity of potential federal interest, including unlawful use of firearms, violence, sales to minors, money laundering, amounts of marijuana inconsistent with purported compliance with state or local law, marketing or excessive financial gains similarly inconsistent with state or local law, illegal possession or sale of other controlled substances, and ties to criminal enterprises. “For example,” according to the memo, “prosecution of individuals with cancer or other serious illnesses who use marijuana as part of a recommended treatment regimen consistent with applicable state law, or those caregivers in clear and unambiguous compliance with existing state law who provide such individuals with marijuana, is unlikely to be an efficient use of limited federal resources. On the other hand, prosecution of commercial enterprises that unlawfully market and sell marijuana for profit continues to be an enforcement priority of the Department.”
The memo does not “legalize” marijuana or provide a legal defense to a violation of federal law, nor is it intended to create any privileges, benefits or rights, substantive or procedural, enforceable by any individual, party or witness in any administrative, civil or criminal matter. Rather, the memo is intended solely as a guide to the exercise of investigative and prosecutorial discretion.
Fourteen states have enacted laws in some form addressing the use of marijuana for medical purposes. They are: Alaska, California, Colorado, Hawaii, Maine, Maryland, Michigan, Montana, Nevada, New Mexico, Oregon, Rhode Island, Vermont and Washington. A copy of the guidelines, in a memo from Deputy Attorney General David W. Ogden to United States Attorneys, can be found at: http://blogs.usdoj.gov/blog/archives/192.
Reprinted with permission. © CCH
<p>Feds relax enforcement policy in states with medical marijuana laws On October 19, 2009, Attorney General Eric Holder announced formal guidelines for federal prosecutors in states that have enacted laws authorizing the use of marijuana for medical purposes. The guidelines</p>
/news/alerts/feds_relax_enforcement_policy_in_states_with_medical_marijuana_laws.aspx